Submitted by Anonymous (not verified) on 24 February 2026 - 11:52
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 15, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 15, Status: Authorised